IRIS PubliCatt

Agnes, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.929
NA - Nord America 4.643
AS - Asia 1.548
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 11
OC - Oceania 10
Totale 11.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.608
DE - Germania 1.765
SE - Svezia 896
CN - Cina 821
UA - Ucraina 593
IT - Italia 445
SG - Singapore 283
IE - Irlanda 282
FR - Francia 244
GB - Regno Unito 176
FI - Finlandia 172
ID - Indonesia 159
PL - Polonia 157
IN - India 83
RU - Federazione Russa 77
TR - Turchia 77
BE - Belgio 48
IR - Iran 30
HK - Hong Kong 29
KR - Corea 23
JP - Giappone 21
CA - Canada 19
EU - Europa 13
MX - Messico 13
CH - Svizzera 12
CZ - Repubblica Ceca 11
AU - Australia 9
CI - Costa d'Avorio 9
ES - Italia 9
BR - Brasile 8
NL - Olanda 8
RO - Romania 7
PT - Portogallo 6
VN - Vietnam 5
BG - Bulgaria 4
CL - Cile 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
EE - Estonia 3
GR - Grecia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
EC - Ecuador 2
LT - Lituania 2
MD - Moldavia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.175
Salva come PNG Salva come JPEG
Città #
Chandler 979
Ashburn 419
Jacksonville 338
Dublin 275
San Mateo 269
Ann Arbor 195
Singapore 189
Nanjing 184
Jakarta 157
New York 125
Warsaw 122
Boston 118
Wilmington 118
Nürnberg 112
Woodbridge 111
Marseille 103
Dearborn 91
Lawrence 89
Seattle 85
Beijing 84
Bremen 82
Redwood City 81
Cattolica 76
Rome 73
Nanchang 69
Houston 68
Izmir 66
Helsinki 62
Moscow 60
Fairfield 57
Milan 56
Shenyang 56
Hangzhou 54
Princeton 53
Chicago 50
Lancaster 47
Munich 47
Brussels 44
Hebei 42
Zhengzhou 42
University Park 38
Augusta 33
Detroit 33
Mountain View 33
Andover 32
Tianjin 28
Changsha 27
Kunming 26
Norwalk 26
Shanghai 22
Hong Kong 20
Boardman 19
Jiaxing 19
Jinan 18
Kish 18
Chengdu 17
Los Angeles 17
Cambridge 16
Leawood 16
Ningbo 15
Pune 15
Fremont 14
Guangzhou 14
Hounslow 14
Kraków 13
London 12
San Giovanni Bianco 12
Washington 11
Hefei 10
Abidjan 9
Segrate 9
Seongnam 9
Lanzhou 8
Mcallen 7
Mexico City 7
San Diego 7
Seoul 7
Ardabil 6
Brno 6
Buffalo 6
Santa Maria 6
São Paulo 6
Tokyo 6
Ypsilanti 6
Baotou 5
Berlin 5
Changchun 5
Costa Mesa 5
Madrid 5
Monmouth Junction 5
Phoenix 5
Redmond 5
Taizhou 5
Zurich 5
Antwerpen 4
Fuzhou 4
Hanoi 4
Hanover 4
Mumbai 4
Padova 4
Totale 6.115
Salva come PNG Salva come JPEG
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 294
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 207
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 196
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 179
Duplex Doppler in the postoperative monitoring of liver transplant recipients 156
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 150
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 145
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 142
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 139
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 139
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 137
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 134
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 131
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 114
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 114
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 113
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 111
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 108
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 107
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 104
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 103
Prediction of 6-month survival after liver transplantation using Cox regression. 101
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 100
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 100
Psychological risk factors for graft rejection among liver transplant recipients 99
Model for end-stage liver disease dynamic stratification of survival benefit 98
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 97
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 96
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 96
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 93
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 93
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 92
Fungal infections after liver transplantation: incidence and outcome 92
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 92
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 91
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 91
Psychological risk factors for graft rejection among liver transplant recipients 91
Liver transplantation in patients with alcoholic liver disease: A retrospective study 89
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 88
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 87
Prediction of 6-month survival after liver transplantation using Cox regression 86
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 86
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 86
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 85
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 83
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 82
Lamivudine-induced muscle mitochondrial toxicity 82
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 82
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 82
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 81
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 80
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 80
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 79
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 79
Pancreatic function assessment 78
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 78
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 78
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 77
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 77
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 77
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 76
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 75
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 74
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 74
Overextended Criteria Donors: Experience of an Italian Transplantation Center 74
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 73
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 73
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 72
Primary difunction after liver trasplantation: donor or recipients fault? 71
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 70
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 69
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 69
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 69
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 68
Is primary nonfunction still a suitable indication for liver retransplantation? 68
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 68
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 68
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 67
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 67
Celiac axis compression syndrome in liver transplantation 66
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 64
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 63
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 62
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 62
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 61
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 61
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 61
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 61
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 60
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 60
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 60
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 60
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 59
Effect of liver transplantation on intestinal permeability and correlation with infection episodes 59
Should retransplantation still be considered for primary non-function after liver transplantation? 58
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 58
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 58
Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study 58
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 57
Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011 56
Totale 9.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.047 0 0 0 71 114 125 143 67 121 127 150 129
2020/20211.210 80 125 16 120 177 53 136 19 145 76 239 24
2021/20221.440 84 185 28 104 70 47 10 257 61 83 196 315
2022/20232.789 319 361 258 432 180 360 148 207 305 70 119 30
2023/20241.347 54 426 39 146 58 176 89 43 16 48 127 125
2024/2025358 44 78 235 1 0 0 0 0 0 0 0 0
Totale 11.305